PHARMACOGENOMIC-GUIDED PRESCRIBING IN MAJOR DEPRESSIVE DISORDER AND SCHIZOPHRENIA: A SYSTEMATIC REVIEW
Introduction: Pharmacogenomic (PGx)-guided prescribing has been proposed to improve psychotropic medication selection by identifying clinically relevant gene–drug interactions. Evidence from controlled trials varies by diagnosis, outcome, and follow-up period. This review assessed PGx-guided prescribing compared with s...